These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3284555)

  • 1. Differential neutralizing capacity to different human immunodeficiency virus (HIV) isolates by a rabbit antiserum against LAV: sensitive assays with HTLV-I-positive MT-4 cells.
    Yoshiyama H; Nakashima H; Kobayashi S; Yamamoto N
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):91-8. PubMed ID: 3284555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable and conserved neutralization antigens of human immunodeficiency virus.
    Weiss RA; Clapham PR; Weber JN; Dalgleish AG; Lasky LA; Berman PW
    Nature; 1986 Dec 11-17; 324(6097):572-5. PubMed ID: 2431324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
    Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
    J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.
    McKeating JA; McKnight A; McIntosh K; Clapham PR; Mulder C; Weiss RA
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3327-33. PubMed ID: 2575137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV).
    Harada S; Purtilo DT; Koyanagi Y; Sonnabend J; Yamamoto N
    J Immunol Methods; 1986 Sep; 92(2):177-81. PubMed ID: 3639115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV).
    Harada S; Kobayashi N; Koyanagi Y; Yamamoto N
    Virology; 1987 Jun; 158(2):447-51. PubMed ID: 2438845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
    Harada S; Koyanagi Y; Yamamoto N
    Science; 1985 Aug; 229(4713):563-6. PubMed ID: 2992081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I; Bienzle U; Hunsmann G
    AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
    Wang S; Pal R; Mascola JR; Chou TH; Mboudjeka I; Shen S; Liu Q; Whitney S; Keen T; Nair BC; Kalyanaraman VS; Markham P; Lu S
    Virology; 2006 Jun; 350(1):34-47. PubMed ID: 16616287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.
    Nara PL; Hatch WC; Dunlop NM; Robey WG; Arthur LO; Gonda MA; Fischinger PJ
    AIDS Res Hum Retroviruses; 1987; 3(3):283-302. PubMed ID: 3481271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of anti-HIV neutralizing antibodies by synthetic peptides.
    Chanh TC; Dreesman GR; Kanda P; Linette GP; Sparrow JT; Ho DD; Kennedy RC
    EMBO J; 1986 Nov; 5(11):3065-71. PubMed ID: 3466790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135).
    Böttiger B; Karlsson A; Andreasson PA; Naucler A; Costa CM; Biberfeld G
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):525-33. PubMed ID: 2590556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generation of an HTLV-III variant by neutralizing antibody.
    Robert-Guroff M; Reitz MS; Robey WG; Gallo RC
    J Immunol; 1986 Nov; 137(10):3306-9. PubMed ID: 3639908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.
    Spenlehauer C; Kirn A; Aubertin AM; Moog C
    J Virol; 2001 Mar; 75(5):2235-45. PubMed ID: 11160727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.
    Goudsmit J; Thiriart C; Smit L; Bruck C; Gibbs CJ
    Vaccine; 1988 Jun; 6(3):229-32. PubMed ID: 3166553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I.
    Blanchard S; Astier-Gin T; Moynet D; Edouard E; Guillemain B
    Virology; 1998 May; 245(1):90-8. PubMed ID: 9614870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrow host range of AIDS-related retroviruses (YU-1, 2, 3, 4) isolated from Japanese hemophiliacs: inability to infect H9, Molt-4, and MT-4 cells.
    Yoshiyama H; Harada S; Kajii T; Yamamoto N
    Jpn J Cancer Res; 1986 Jun; 77(6):514-6. PubMed ID: 3015850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
    McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
    J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor promoter, TPA, enhances replication of HTLV-III/LAV.
    Harada S; Koyanagi Y; Nakashima H; Kobayashi N; Yamamoto N
    Virology; 1986 Oct; 154(2):249-58. PubMed ID: 3639669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.